Safety and efficacy of valsartan versus enalapril in heart failure patients

2002 ◽  
Vol 85 (2-3) ◽  
pp. 261-270 ◽  
Author(s):  
Ronnie Willenheimer ◽  
Claes Helmers ◽  
Emil Pantev ◽  
Erik Rydberg ◽  
Per Löfdahl ◽  
...  
Keyword(s):  
Heart Failure ◽  
Safety And Efficacy ◽  
Heart Failure Patients

scholarly journals Initial Safety and Efficacy Experience with Extended Release Milrinone in No-Option Stage D Heart Failure Patients

2016 ◽  
Vol 22 (8) ◽  
pp. S67-S68
Author(s):  
Shane Nanayakkara ◽  
Viv Mak ◽  
Karina Crannitch ◽  
Peter Bergin ◽  
David Kaye
Keyword(s):  
Heart Failure ◽  
Extended Release ◽  
Safety And Efficacy ◽  
Heart Failure Patients ◽  
Stage D

Prednisone in Uric Acid Lowering in Symptomatic Heart Failure Patients with Hyperuricemia — The PUSH-PATH3 Study

2015 ◽  
Vol 42 (5) ◽  
pp. 866-869 ◽  
Author(s):  
Hong Meng ◽  
Gang Liu ◽  
Jianlong Zhai ◽  
Yuzhi Zhen ◽  
Qingzhen Zhao ◽  
...  
Keyword(s):  
Heart Failure ◽  
Renal Function ◽  
Uric Acid ◽  
Serum Creatinine ◽  
Serum Uric Acid ◽  
Clinical Status ◽  
Safety And Efficacy ◽  
Symptomatic Heart Failure ◽  
Heart Failure Patients ◽  
Short Time

Objective.To determine the safety and efficacy of prednisone in patients with symptomatic heart failure (HF) and hyperuricemia.Methods.Prednisone therapy was administered for a short time to 191 symptomatic HF patients with hyperuricemia (serum uric acid > 7 mg/dl).Results.Prednisone significantly reduced serum uric acid by 2.99 mg/dl (p < 0.01) and serum creatinine by 0.17 mg/dl (p < 0.01). These favorable effects were associated with a remarkable increase in urine output, improvement in renal function, and improvement in clinical status.Conclusion.Prednisone can be used safely in symptomatic HF patients with hyperuricemia.

THE SAFETY AND EFFICACY OF RESISTANCE TRAINING IN STABLE HEART FAILURE PATIENTS. 11

1998 ◽  
Vol 18 (5) ◽  
pp. 351
Author(s):  
Tara. M. Falconer ◽  
Trina. L. Logan ◽  
James A. Stone ◽  
Robert G. Haennel
Keyword(s):  
Heart Failure ◽  
Resistance Training ◽  
Safety And Efficacy ◽  
Heart Failure Patients

Safety and efficacy of doxazosin as an 'add-on' antihypertensive therapy in mild to moderate heart failure patients

2009 ◽  
Vol 64 (4) ◽  
pp. 485-491 ◽  
Author(s):  
R. Spoladore ◽  
R. Roccoforte ◽  
G. Fragasso ◽  
C. Gardini ◽  
A. Palloshi ◽  
...  
Keyword(s):  
Heart Failure ◽  
Antihypertensive Therapy ◽  
Safety And Efficacy ◽  
Heart Failure Patients ◽  
Moderate Heart Failure
Sign in / Sign up

Export Citation Format

Share Document